International Consol. Chemical Co. v. Commissioner

*408 Before IVINS, MARQUETTE, and MORRIS.

This appeal is from a determination by the Commissioner of deficiencies in income and profits taxes for the years 1919, 1920, and 1921 amounting in the aggregate to $45,426.86.

From the evidence submitted at the hearing, the Board makes the following

FINDINGS OF FACT.

The taxpayer was a Delaware corporation, now liquidated and dissolved, having its principal office in New York City during the years 1919, 1920, and 1921.

It was organized on June 30, 1919, when it acquired the assets or the capital stock of nine separate businesses and issued 19,360 shares of its capital stock therefor, of par value $100 per share.

The number of shares of stock in the taxpayer issued for the assets or stock of the respective predecessor businesses were:

*2395 The taxpayers's stock was thereafter owned in the percentages noted and by the individuals named, reference also being made to their prior proportionate interest in the respective predecessor businesses:

*2396 *409 There were three separate predecessor businesses done under the name of "E. Virgil Neal."

The Federal tax returns filed by Dae Health Laboratories, Inc., for the periods noted showed net income as follows:

The excess-profits-tax returns filed by that corporation showed:

The return last above referred to contained the notation "Final report as independent corporation. Affiliated with International Consolidated Chemical Co."

In its returns for the six months of 1919 and the year 1920, the taxpayer showed: Capital stock for 1919, $1,963,000; capital stock and surplus for 1920, $2,143,547.48. The Commissioner deducted $486,365.51 therefrom in 1919 and $486,439.61 in 1920, both included in the returns as alleged good will, the value of which had not been established, *2397 and by reason of those deductions, and others as to which no question has been raised by this appeal, determined deficiencies in income and profits taxes for the six months of 1919, the year 1920, and the year 1921, in the aggregate amount of $45,426.86. From those determinations the taxpayer appeals.

DECISION.

The determination of the Commissioner is approved.

OPINION.

IVINS: The Commissioner contended that section 331 of the Revenue Act of 1918 applied to this taxpayer. It is unnecessary to determine this question. The other question raised relates to the value of intangibles acquired upon the organization of the taxpayer. Upon that issue the evidence made available for presentation by the taxpayer's representatives was very meagre. The taxpayer was dissolved in 1921 and all of its books and records were removed to Europe. No data whatever were presented to us affording information as to the method by which the organization of the taxpayer was effected in 1919, no balance sheets or accounting records relating to the predecessor business (with the exception of the tax returns of one *410 company), nothing as to the accounts of the taxpayer, and no information*2398 as to any of the companies that might assist in a determination of the valuation of tangible property, much less the value of intangibles.

The taxpayer alleged in its petition a valuation for intangible assets acquired on organization by the issuance of stock therefor as follows:

The Commissioner denied the allegations by his answer. The only attempt made at the hearing to prove such value was through the introduction, as evidence, of the tax returns of Dae Health Laboratories, showing therein the net income of that company as reported for the several years.

Calling the average net income of Dae Health Laboratories about $250,000, the taxpayer then attempted to prove the valuation of intangibles in the following way:

It deducted the alleged value of intangibles ($486,365.51) from the par value of the taxpayer's capital stock ($1,963,000) and called the balance the value of the tangible assets. It then figured that 10 per cent would be a fair and proper return upon tangible property, and so deducted 10 per cent of $1,476,634.49 (the difference between the par*2399 of capital stock issued, $1,963,000 and $486,365.51, the alleged value of intangibles) from the alleged average income of the Dae Health Laboratories and, getting a resultant of some $105,000, proceeded to capitalize that amount at 15 per cent, thereby arriving at a claimed value for intangibles of some $705,000, by which it justified its valuation of $486,365.51.

The very foundation of any formula or method of determining the valuation of intangible property is knowledge, exact as possible, of the cost of tangible property, associated with the intangible, in the production of income. Its very foundation is knowledge, exact as possible, of the cost value of tangible property. That necessary element is lacking in the present appeal. The deduction of the alleged value of intangibles from the par value of stock constitutes the use of an assumption to prove its own verity as a fact, instead of proving that fact by the use of other facts. The attempt involves a circuitous process of reasoning which is utterly lacking in logic. Its only defense is that it is the best that could be done under the circumstances. It is insufficient to convince us that the determination made by*2400 the Commissioner was incorrect. That determination must be sustained upon the authority of Appeal of*411 ; ; ; . See also, ; and .

On reference to the Board, ARUNDELL took no part in the consideration.